Latest Strategy News

FireFly Metals has successfully raised approximately A$139 million through a multi-part equity raising, significantly bolstering its cash reserves to advance its flagship Green Bay Copper-Gold Project in Newfoundland. The company also closed its oversubscribed Share Purchase Plan early, reflecting strong investor demand.

Exultant Mining has launched an aggressive exploration campaign at its Black Hammer Project in New South Wales, collecting 76 rock chip samples and expanding its tenure with a newly granted exploration licence. The company is progressing land access agreements and plans to commence drilling in early 2026.

Lefroy Exploration has received a second $0.75 million cash advance from BML Ventures, reinforcing its funding position ahead of key production milestones at the Lucky Strike Gold Project.

Netwealth Group Limited will compensate members affected by the First Guardian Master Fund collapse with $101 million, impacting its 1H26 profit but aiming to restore member confidence swiftly.

Hawsons Iron Ltd has declared a JORC-compliant Probable Ore Reserve of 2.3 billion tonnes and completed a positive Pre-Feasibility Study supporting a 26-year, 12Mtpa magnetite concentrate project in New South Wales.

Torque Metals has raised $16.2 million through a $15 million placement and early option exercises, setting the stage for an aggressive drilling campaign at its Paris Gold Project in Western Australia.

RocketDNA has secured approximately A$1 million in new orders from major mining clients, expanding its autonomous drone deployments and software services across Australia and Africa.

Middle Island Resources has appointed Peter Spiers as CEO, aiming to accelerate exploration and development of its Serbian projects with his extensive industry expertise.

Truscott Mining Corporation has initiated a $1.44 million capital raise through a share placement accompanied by unlisted options, aiming to bolster its exploration and development efforts.

Opthea Limited has announced a strategic pivot to develop OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women, aiming for ASX reinstatement in 2026. The company leverages strong intellectual property and cash reserves to pursue orphan drug designation and clinical development.

Humm Group has received a shareholder notice to remove key directors alongside a non-binding acquisition proposal from Credit Corp, signaling potential major changes ahead.

Variscan Mines has secured government approval for its Preliminary Mining Plan, enabling critical pre-works and trial mining at the San Jose Mine in Spain. This milestone accelerates the company’s strategy to restart production with minimal capital expenditure.